The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Malignant neoplasms following bone marrow transplantation
Abstract
We undertook an analysis of 2,150 recipients of bone marrow transplant (BMT) at the University of Minnesota to determine the incidence of post- BMT malignant neoplasms (MNs). Fifty-one patients developed 53 MNs, compared with 4.3 expected from general population rates (standardized incidence ratio [SIR], 11.6, 95% confidence interval [CI], 8.2–14.5). These included 22 occurrences of B-cell lymphoproliferative disorder (BLPD), 17 solid nonhematopoietic tumors, 10 myelodysplastic syndromes (MDS), 1 acute myelogenous leukemia (AML), 2 non-Hodgkin's lymphoma (NHL), and 1 Hodgkin's disease (HD). The estimated actuarial incidence of any post-BMT malignancy was 9.9% +/- 2.3% at 13 years posttransplant. The cumulative probability of BLPD plateaued at 1.6% +/- 0.3% by 4 years from transplant and factors independently associated with increased risk included in vitro T-cell depletion of marrow (relative risk (RR) = 11.9, P < .001), HLA mismatch (RR = 8.9, P < .001), use of antithymocyte globulin (ATG) for graft versus host disease (GVHD) prophylaxis (RR = 5.9, P < .001) or in the preparative regimen (RR = 3.1, P = .03) and primary immunodeficiency (RR = 2.5, P = .06). The cumulative probability of developing solid malignancy was 5.6% +/- 2.2% at 13 years from BMT. Malignant melanomas were the most common (SIR, 10.3, 95% CI 1.9 to 25.4). The actuarial incidence of MDS/AML plateaued at 2.1% +/- 0.8% at 9 years and was seen most often in older patients receiving autologous peripheral blood stem cells for HD or NHL. These data document that BMT recipients are at an increased risk of later malignancy, which may add significant morbidity and mortality to the transplant process. Methods for screening and identification of individuals at increased risk need to be addressed in future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M., Ho, M., Griffith, B. P., Hakala, T. R., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90994-2 · Cited by 1,234
Second Neoplasms after Acute Lymphoblastic Leukemia in Childhood
Neglia, J. P., Meadows, A. T., Robison, L. L., Kim, T. H., Newton, W. A., Ruymann, F. B., Sather, H. N., & Hammond, G. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251902 · Cited by 549
Self-citationBreast Cancer After Treatment of Hodgkin's Disease
Hancock, S. L., Tucker, M. A., & Hoppe, R. T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.25 · Cited by 536
Malignant Tumors Occurring after Treatment of Aplastic Anemia
Socié, G., Henry-Amar, M., Bacigalupo, A. P., Hows, J., Tichelli, A., Ljungman, P. T., McCann, S. R., Frickhofen, N., Veer-Korthof, E. T. V., & Gluckman, É. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291603 · Cited by 458
Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia
Witherspoon, R. P., Fisher, L. D., Schoch, G., Martin, P., Sullivan, K. M., Sanders, J., Deeg, H. J., Doney, K., Thomas, D., Storb, R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909213211203 · Cited by 409
Incidence of second primary tumours among childhood cancer survivors
Hawkins, M., Draper, G., & Kingston, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.200 · Cited by 332
Stone, R. M., Neuberg, D., Soiffer, R., Takvorian, T., Whelan, M., Rabinowe, S. N., Aster, J. C., Leavitt, P., Mauch, P., & Freedman, A. S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2535 · Cited by 252
Miller, J., Arthur, D., Litz, C., Neglia, J., Miller, W., & Weisdorf, D. (1994) · Blood · doi:10.1182/blood.v83.12.3780.3780 · Cited by 234
Self-citationSecond Cancers Among Long-term Survivors of Non-Hodgkin's Lymphoma
Travis, L. B., Curtis, R. E., Glimelius, B., Holowaty, E., Leeuwen, F. E. V., Lynch, C. F., Adami, J., Gospodarowicz, M., Wacholder, S., Inskip, P., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.23.1932 · Cited by 222
Cited by
Solid Cancers after Bone Marrow Transplantation
Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socié, G., Travis, L. B., Horowitz, M. M., Witherspoon, R. P., Hoover, R. N., Sobocinski, K. A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361301 · Cited by 965
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Gyurkocza, B., & Sandmaier, B. M. (2014) · Blood · doi:10.1182/blood-2014-02-514778 · Cited by 614
Bhatia, S., Francisco, L., Carter, A., Sun, C.-L., Baker, K. S., Gurney, J. G., McGlave, P. B., Nademanee, A., O'Donnell, M., Ramsay, N. K. C., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082933 · Cited by 540
Self-citationPost-Transplant Lymphoproliferative Disorders
Gottschalk, S., Rooney, C. M., & Heslop, H. E. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104727 · Cited by 489
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Landgren, O., Gilbert, E. S., Rizzo, J. D., Socié, G., Banks, P. M., Sobocinski, K. A., Horowitz, M. M., Jaffe, E. S., Kingma, D. W., Travis, L. B., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178046 · Cited by 400
Metadata
- Authors
- Bhatia, S., Ramsay, N., Steinbuch, M., Dusenbery, K., Shapiro, R., Weisdorf, D., Robison, L., Miller, J., & Neglia, J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-05-01
- Volume
- 87
- Issue
- 9
- Pages
- 3633-3639
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1933695467
- Cited by
- 410
- References
- 15
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignant neoplasms following bone marrow transplantation. https://app.cochat.ai/papers/10.1182/blood.v87.9.3633.bloodjournal8793633
- The paper
- Bhatia, S., Ramsay, N., Steinbuch, M., Dusenbery, K., Shapiro, R., Weisdorf, D., Robison, L., Miller, J., & Neglia, J. (1996). Malignant neoplasms following bone marrow transplantation. Blood. https://doi.org/10.1182/blood.v87.9.3633.bloodjournal8793633
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.